Skip to main content
. 2023 May 10;2023(5):CD014682. doi: 10.1002/14651858.CD014682.pub2

Brown 2015.

Methods Double‐blind, placebo‐controlled, parallel, 2‐arm RCT
Participants Patients with multiple sclerosis
n = 38
Interventions Duloxetine
Placebo
Outcomes Pain
PGIC
Depression
Quality of life
Sleep
Notes Unable to ascertain pain duration, unsure if chronic